Prolonged elevation of galanin and tachykinin expression in mucosal and myenteric enteric nerves in trinitrobenzene sulphonic acid colitis

Neurogastroenterology and Motility

Volumn 20, Issue 4, 2008, Pages 392-406

  Simpson, J ^a   Sundler, F ^b   Humes, D J ^a   Jenkins, D ^a   Wakelin, D ^a   Scholefield, J H ^a   Spiller, R C ^a,c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Colitis; Galanin; Nerve; Plasticity; Tachykinins

Indexed keywords

GALANIN; GENE PRODUCT; NEUROPEPTIDE; NEUROPEPTIDE K; TACHYKININ; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

ANIMALS; COLITIS; GALANIN; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MYENTERIC PLEXUS; NEUROFILAMENT PROTEINS; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; TRINITROBENZENESULFONIC ACID; UBIQUITIN THIOLESTERASE;

EID: 41149105907     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2007.01037.x     Document Type: Article

References (62)

1. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999 44 : 400 6.
2. Simpson J, Neal KR, Scholefield JH, Spiller RC. Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol 2003 15 : 1005 10.
3. Simpson J, Sundler F, Jenkins D, Scholefield JH, Spiller RC. Increased expression of substance P, neuropeptide K and galanin in mucosal nerves in patients with painful diverticular disease. Gastroenterology 2004 126 : A218.
4. Simpson J, Haji-Suyoi A, Jenkins D, Scholefield JH, Spiller RC. Quantification of neurological changes in resection specimens with complicated and uncomplicated diverticular disease. Gastroenterology 2002 122 : M1506.
5. Liebregts T, Adam B, Bertel A et al. Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model. Neurogastroenterol Motil 2005 17 : 410 4.
6. Cho SH, Park H, Chung JP et al. [Altered colonic transit in TNBS-induced experimental colitis in guinea pig and distribution of nitric oxide synthase in the colonic wall]. Korean J Gastroenterol 2004 44 : 308 13.
7. Zhao A, Bossone C, Pineiro-Carrero V, Shea-Donohue T. Colitis-induced alterations in adrenergic control of circular smooth muscle in vitro in rats. J Pharmacol Exp Ther 2001 299 : 768 74.
8. Evangelista S, Maggi M, Renzetti AR. Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats. Neuropeptides 1996 30 : 425 8.
9. Hosseini JM, Goldhill JM, Bossone C, Pineiro-Carrero V, Shea-Donohue T. Progressive alterations in circular smooth muscle contractility in TNBS-induced colitis in rats. Neurogastroenterol Motil 1999 11 : 347 56.
10. Miampamba M, Sharkey KA. Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats. Neurogastroenterol Motil 1998 10 : 315 29.
11. Sanovic S, Lamb DP, Blennerhassett MG. Damage to the enteric nervous system in experimental colitis. Am J Pathol 1999 155 : 1051 7.
12. Linden DR, Couvrette JM, Ciolino A et al. Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon. Neurogastroenterol Motil 2005 17 : 751 60.
13. Wallace JL, Keenan CM, Gale D, Shoupe TS. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology 1992 102 : 18 27.
14. Ekblad E, Sjuve R, Arner A, Sundler F. Enteric neuronal plasticity and a reduced number of interstitial cells of Cajal in hypertrophic rat ileum. Gut 1998 42 : 836 44.
15. Ekblad E, Winther C, Ekman R, Hakanson R, Sundler F. Projections of peptide-containing neurons in rat small intestine. Neuroscience 1987 20 : 169 88.
16. Ekblad E, Ekman R, Hakanson R, Sundler F. Projections of peptide-containing neurons in rat colon. Neuroscience 1988 27 : 655 74.
17. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999 8 : 135 60.
18. Poli E, Lazzaretti M, Grandi D, Pozzoli C, Coruzzi G. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. Neurochem Res 2001 26 : 1085 93.
19. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002 51 : 410 3.
20. Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004 19 : 1217 24.
21. Sun FF, Lai PS, Yue G et al. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat. Inflammation 2001 25 : 33 45.
22. Eysselein VE, Reinshagen M, Cominelli F et al. Calcitonin gene-related peptide and substance P decrease in the rabbit colon during colitis. A time study. Gastroenterology 1991 101 : 1211 9.
23. Bernstein CN, Robert ME, Eysselein VE. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am J Gastroenterol 1993 88 : 908 13.
24. Koch TR, Carney JA, Go VL. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 1987 32 : 369 76.
25. Watanabe T, Kubota Y, Muto T. Substance P containing nerve fibers in rectal mucosa of ulcerative colitis. Dis Colon Rectum 1997 40 : 718 25.
26. Goldin E, Karmeli F, Selinger Z, Rachmilewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989 34 : 754 7.
27. Keranen U, Jarvinen H, Kiviluoto T, Kivilaakso E, Soinila S. Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig Dis Sci 1996 41 : 1658 64.
28. Vento P, Soinila S. Quantitative comparison of growth-associated protein GAP-43, neuron-specific enolase, and protein gene product 9.5 as neuronal markers in mature human intestine. J Histochem Cytochem 1999 47 : 1405 16.
29. Goode T, O'Connor T, Hopkins A et al. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P. J Cell Physiol 2003 197 : 30 41.
30. Goode T, O'Connell J, Anton P et al. Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut 2000 47 : 387 96.
31. Lourenssen S, Wells RW, Blennerhassett MG. Differential responses of intrinsic and extrinsic innervation of smooth muscle cells in rat colitis. Exp Neurol 2005 195 : 497 507.
32. Green T, Dockray GJ. Characterization of the peptidergic afferent innervation of the stomach in the rat, mouse and guinea-pig. Neuroscience 1988 25 : 181 93.
33. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004 201 : 167 80.
34. Kolbel CB, Mayer EA, Holtmann G et al. Effects of neurokinins on human colonic motility. Neurogastroenterol Motil 1994 6 : 119 27.
35. Scheurer U, Drack E, Halter F. Substance P activates rat colonic motility via excitatory and inhibitory neural pathways and direct action on muscles. J Pharmacol Exp Ther 1994 271 : 7 13.
36. Silkoff P, Karmeli F, Goldin E et al. Effect of substance P on rat gastrointestinal transit. Dig Dis Sci 1988 33 : 74 7.
37. Lordal M, Navalesi G, Theodorsson E, Maggi CA, Hellstrom PM. A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine. Br J Pharmacol 2001 134 : 215 23.
38. Cooke HJ, Sidhu M, Fox P, Wang YZ, Zimmermann EM. Substance P as a mediator of colonic secretory reflexes. Am J Physiol 1997 272 : G238 45.
39. Eutamene H, Theodorou V, Fioramonti J, Bueno L. Implication of NK1 and NK2 receptors in rat colonic hypersecretion induced by interleukin 1 beta: role of nitric oxide. Gastroenterology 1995 109 : 483 9.
40. Toulouse M, Coelho AM, Fioramonti J, Lecci A, Maggi C, Bueno L. Role of tachykinin NK2 receptors in normal and altered rectal sensitivity in rats. Br J Pharmacol 2000 129 : 193 9.
41. Di Sebastiano P, Grossi L, Di Mola FF et al. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci 1999 44 : 439 44.
42. Milner P, Crowe R, Kamm MA, Lennard-Jones JE, Burnstock G. Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology 1990 99 : 666 75.
43. Tomita R, Munakata K, Aoki N, Tanjoh K, Kurosu Y. A study on the peptidergic nerves (VIP, substance P) in the colon of patients with diverticular disease. Regul Pept 1993 46 : 244 6.
44. Liu L, Shang F, Markus I, Burcher E. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease. J Pharmacol Exp Ther 2002 302 : 627 35.
45. Marrero JA, Matkowskyj KA, Yung K, Hecht G, Benya RV. Dextran sulfate sodium-induced murine colitis activates NF-kappaB and increases galanin-1 receptor expression. Am J Physiol Gastrointest Liver Physiol 2000 278 : G797 804.
46. Matkowskyj KA, Danilkovich A, Marrero J, Savkovic SD, Hecht G, Benya RV. Galanin-1 receptor up-regulation mediates the excess colonic fluid production caused by infection with enteric pathogens. Nat Med 2000 6 : 1048 51.
47. Benya RV, Matkowskyj KA, Danilkovich A, Hecht G. Galanin causes Cl- secretion in the human colon. Potential significance of inflammation-associated NF-kappa B activation on galanin-1 receptor expression and function. Ann N Y Acad Sci 1998 863 : 64 77.
48. Benya RV, Marrero JA, Ostrovskiy DA, Koutsouris A, Hecht G. Human colonic epithelial cells express galanin-1 receptors, which when activated cause Cl- secretion. Am J Physiol 1999 276 : G64 72.
49. Xu XJ, Hokfelt T, Bartfai T, Wiesenfeld-Hallin Z. Galanin and spinal nociceptive mechanisms: recent advances and therapeutic implications. Neuropeptides 2000 34 : 137 47.
50. Calza L, Pozza M, Arletti R, Manzini E, Hokfelt T. Long-lasting regulation of galanin, opioid, and other peptides in dorsal root ganglia and spinal cord during experimental polyarthritis. Exp Neurol 2000 164 : 333 43.
51. Shadiack AM, Zigmond RE. Galanin induced in sympathetic neurons after axotomy is anterogradely transported toward regenerating nerve endings. Neuropeptides 1998 32 : 257 64.
52. Belai A, Boulos PB, Robson T, Burnstock G. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut 1997 40 : 767 74.
53. Schneider J, Jehle EC, Starlinger MJ et al. Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease. Neurogastroenterol Motil 2001 13 : 255 64.
54. Hockerfelt U, Henriksson R, Franzen L, Norrgard O, Forsgren S. Irradiation induces marked immunohistochemical expression of vasoactive intestinal peptide in colonic mucosa of man. Dig Dis Sci 1999 44 : 393 401.
55. Coupar IM. Stimulation of sodium and water secretion without inhibition of glucose absorption in the rat jejunum by vasoactive intestinal peptide (VIP). Clin Exp Pharmacol Physiol 1976 3 : 615 8.
56. Krejs GJ, Fordtran JS, Fahrenkrug J et al. Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology 1980 78 : 722 7.
57. Grider JR. Identification of neurotransmitters regulating intestinal peristaltic reflex in humans. Gastroenterology 1989 97 : 1414 9.
58. Sandgren K, Lin Z, Ekblad E. Differential effects of VIP and PACAP on survival of cultured adult rat myenteric neurons. Regul Pept 2003 111 : 211 7.
59. Shen Z, Larsson LT, Malmfors G, Absood A, Hakanson R, Sundler F. A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprung's disease. Cell Tissue Res 1992 269 : 369 74.
60. Heinemann A, Holzer P. Stimulant action of pituitary adenylate cyclase-activating peptide on normal and drug-compromised peristalsis in the guinea-pig intestine. Br J Pharmacol 1999 127 : 763 71.
61. Colitis: problems in pathologic and clinical diagnosis: indeterminate, microscopic, and diverticulitis. Yale University Workshop Report. October, 2003. Norwalk, Connecticut, USA. J Clin Gastroenterol 2004 38 : S1 57.
62. Di Mario F, Aragona G, Leandro G et al. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci 2005 50 : 581 6.